✦ LIBER ✦

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

✍ Scribed by Spencer, A; Horvath, N; Gibson, J; Prince, H M; Herrmann, R; Bashford, J; Joske, D; Grigg, A; McKendrick, J; Prosser, I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amifostine reduces mucosal damage after

✍ Thieblemont, C; Dumontet, C; Saad, H; Roch, N; Bouafia, F; Arnaud, P; Hequet, O; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

High-dose idarubicin, cyclophosphamide a

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Empirical antimicrobial monotherapy in p

✍ Gernot Reich; Oliver A. Cornely; Michael Sandherr; Thomas Kubin; Stefan Krause; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

High-dose idarubicine, busulphan and mel

✍ Meloni, G; Capria, S; Trasarti, S; Ferrazza, G; Micozzi, A; Petrucci, M T; Simon 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

MBL2 polymorphism and risk of severe inf

✍ Mølle, I; Peterslund, N A; Thiel, S; Steffensen, R 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 125 KB

Cardiac toxicity of high-dose cyclophosp

✍ Samo Zver; Vesna Zadnik; Peter Černelč; Mirta Koželj 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 298 KB